These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30278482)

  • 1. DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study.
    Liu XP; Yin XH; Meng XY; Yan XH; Cao Y; Zeng XT; Wang XH
    Medicine (Baltimore); 2018 Sep; 97(39):e11830. PubMed ID: 30278482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer.
    Liu XP; Yin XH; Yan XH; Zeng XT; Wang XH
    Med Sci Monit; 2018 May; 24():3113-3118. PubMed ID: 29752880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DHCR24 is an independent predictor of progression in patients with non-muscle-invasive urothelial carcinoma, and its functional role is involved in the aggressive properties of urothelial carcinoma cells.
    Lee GT; Ha YS; Jung YS; Moon SK; Kang HW; Lee OJ; Joung JY; Choi YH; Yun SJ; Kim WJ; Kim IY
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S538-45. PubMed ID: 24562935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA ENST00000370438 promotes cell proliferation by upregulating DHCR24 in breast cancer.
    Yan L; Wu X; Zhang Y; Tan Q; Xu J; Wang Y; Wang R; Li Y; Zhao J
    Mol Carcinog; 2023 Jun; 62(6):855-865. PubMed ID: 36946578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
    Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
    [No Abstract]   [Full Text] [Related]  

  • 6. CDCA8 expression and its clinical relevance in patients with bladder cancer.
    Bi Y; Chen S; Jiang J; Yao J; Wang G; Zhou Q; Li S
    Medicine (Baltimore); 2018 Aug; 97(34):e11899. PubMed ID: 30142792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
    Shen C; Liu J; Wang J; Yang X; Niu H; Wang Y
    Dis Markers; 2020; 2020():4312629. PubMed ID: 32454905
    [No Abstract]   [Full Text] [Related]  

  • 8. Opa interacting protein 5 acts as an oncogene in bladder cancer.
    He X; Hou J; Ping J; Wen D; He J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma.
    Dai M; Zhu XL; Liu F; Xu QY; Ge QL; Jiang SH; Yang XM; Li J; Wang YH; Wu QK; Ai ZH; Teng YC; Zhang ZG
    Sci Rep; 2017 Jan; 7():41404. PubMed ID: 28112250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
    Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data.
    Zeng XT; Liu XP; Liu TZ; Wang XH
    Medicine (Baltimore); 2018 Mar; 97(10):e0091. PubMed ID: 29517678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
    Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
    Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
    Tian F; Xu F; Zhang ZY; Ge JP; Wei ZF; Xu XF; Cheng W
    Tumour Biol; 2013 Dec; 34(6):3687-90. PubMed ID: 23807680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
    Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
    EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A five-gene expression signature to predict progression in T1G3 bladder cancer.
    van der Heijden AG; Mengual L; Lozano JJ; Ingelmo-Torres M; Ribal MJ; Fernández PL; Oosterwijk E; Schalken JA; Alcaraz A; Witjes JA
    Eur J Cancer; 2016 Sep; 64():127-36. PubMed ID: 27414486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis.
    Di Stasi D; Vallacchi V; Campi V; Ranzani T; Daniotti M; Chiodini E; Fiorentini S; Greeve I; Prinetti A; Rivoltini L; Pierotti MA; Rodolfo M
    Int J Cancer; 2005 Jun; 115(2):224-30. PubMed ID: 15688385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer.
    Yeh HC; Huang CN; Li CC; Chang LL; Lin HH; Ke HL; Huang AM; Liang PI; Li CF; Wu WJ
    World J Urol; 2016 Jun; 34(6):835-46. PubMed ID: 26433386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
    Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
    Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
    Park J; Song C; Shin E; Hong JH; Kim CS; Ahn H
    Urol Oncol; 2013 Aug; 31(6):849-56. PubMed ID: 21782482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.